- Home
- ENSG vs ELAN Comparison
ENSG vs ELAN Comparison
Compare ENSG & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ENSG | ELAN |
|---|---|---|
| Founded | 1999 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 12.7B |
| IPO Year | 2007 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ENSG | ELAN |
|---|---|---|
| Price | $198.84 | $22.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $202.60 | $27.63 |
| AVG Volume (30 Days) | 314.4K | ★ 5.3M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.13% | N/A |
| EPS Growth | ★ 14.06 | N/A |
| EPS | ★ 5.84 | N/A |
| Revenue | ★ $5,057,841,000.00 | $4,715,000,000.00 |
| Revenue This Year | $17.07 | $8.21 |
| Revenue Next Year | $9.49 | $5.29 |
| P/E Ratio | $34.52 | ★ N/A |
| Revenue Growth | ★ 18.72 | 6.22 |
| 52 Week Low | $118.73 | $8.02 |
| 52 Week High | $218.00 | $27.72 |
Technical Indicators
Market Signals| Indicator | ENSG | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 43.96 | 43.74 |
| Support Level | $173.15 | $22.17 |
| Resistance Level | $215.95 | $25.65 |
| Average True Range (ATR) | 4.35 | 1.02 |
| MACD | -0.38 | -0.07 |
| Stochastic Oscillator | 44.03 | 25.84 |
Price Performance
Historical ComparisonAbout ENSG The Ensign Group Inc.
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.